Navigation Links
South Africa's Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
Date:11/9/2008

Partnership will help alleviate South African power crisis

JOHANNESBURG, South Africa and BOSTON Nov. 9 /PRNewswire/ -- Denham Capital, a leading energy-focused global private equity firm, announced today that it will invest equity of up to R1,5 billion (US $150 million, 95 million pounds Sterling) in BioTherm Energy, a South African developer, owner and operator of renewable and clean energy generation projects.

Commenting on Denham Capital's investment, Buyelwa Sonjica, South Africa Minister of Minerals and Energy said, "Having opened BioTherm's first plant just over a year ago, we are delighted with this substantial investment by Denham Capital, a major foreign investor, in a business that will generate more electricity in South Africa, contribute to the reduction of greenhouse gasses and create more jobs in the South African economy."

The Minister opened the 4.2 MW biogas to power plant, based at the PetroSA facility in Mossel Bay, east of Cape Town, in September 2007. At that time, it was the first private sector renewable power generation project in Southern Africa funded under the Clean Development Mechanism ("CDM") of the Kyoto Protocol, under which the project earns carbon credits because of its contribution to the reduction of greenhouse gasses. Under the European carbon-trading scheme these credits are in turn sold, primarily to European industries, which need to reduce the cost of their compliance liabilities.

The opportunity for small scale, on-site generation in South Africa has grown significantly and BioTherm Energy has secured, and is continuing to develop, a substantial pipeline in waste gas co-generation, biomass and combined heat and power projects, many of which qualify for carbon credits under the Kyoto Protocol. These projects can generate electricity much more rapidly than conventional large-scale power projects, thereby providing needed relief to the South African power system.

Dr. Louis van Pletsen, a Partner and Head of the London Office of Denham Capital, said, "Denham Capital will provide the necessary equity capital for BioTherm Energy to develop, invest or acquire projects totalling approximately 300 MW, equivalent to the electricity needed to supply about 500,000 households. Private sector investment from companies such as BioTherm Energy will be essential in addressing South Africa's energy deficit." He added, "Our investment in BioTherm reflects the range and geographic reach of Denham Capital's energy investment strategy."

Charles Liebenberg, co-founder and CEO of BioTherm Energy, said that a partnership with Denham Capital will allow BioTherm Energy to continue its aggressive expansion programme. He went further to say, "For years South Africa has had cheap energy and an unfortunate result of this is inefficient usage. BioTherm Energy's projects ensure that all forms of energy can be best harnessed to avoid waste, reduce carbon emissions and provide reliable power. The Power Conservation Programme, which will ration electricity supply to all consumers, reflects the severity of the power crisis in South Africa which BioTherm can help address."

BioTherm Energy is targeting energy intensive industries where industrial processes release significant amounts of waste energy both as heat and gasses. BioTherm Energy utilises this wasted energy to produce electricity and/or steam, which it sells to the host site or to third parties, including Eskom, the South African public electricity utility.

BioTherm Energy is also instituting multi-level sustainability in all of its projects through the participation of Black Economic Empowerment ("BEE") partners and community-based development programmes.

"Our investment in BioTherm reflects our strong belief in the potential for innovative solutions to the South African power crisis," said Scott Mackin, a Partner at Denham Capital. "We are delighted to be working to develop this exciting and valuable business, with a highly skilled and committed management team with a proven track record. We believe BioTherm Energy is well positioned to deliver much needed additional clean and reliable power to the Southern African economy."

Notes to editors

About BioTherm Energy:

BioTherm Energy (Pty) Ltd (BioTherm Energy) is a cleaner and renewable energy company based in Johannesburg, South Africa. It develops, owns and operates turn-key energy waste to energy, renewable energy and energy efficiency projects in the sub-utility range of 5 - 100MW. BioTherm Energy makes extensive use of carbon finance as created by Article 12 of the Kyoto Protocol (the "Clean Development Mechanism" or "CDM") to finance projects. The BioTherm Energy geographical target market is Southern Africa. For more information about BioTherm Energy visit http://www.biothermenergy.com.

About Denham Capital:

Denham Capital is a leading global energy-focused private equity firm, with offices in Boston, Houston, Short Hills, New Jersey, London and Sao Paulo. With approximately US$4.3 billion of invested and committed capital, Denham makes direct investments in all segments of the energy and commodities value chain, including oil and gas, mining, timber, power, carbon assets and energy-related infrastructure and services. The firm invests globally, with investments currently in the USA, Canada, South America, Europe, Russia/CIS, Asia and Australia, and across all parts of the capital structure and all stages of the corporate and asset lifecycle, from development projects to mature, operating businesses. Denham typically targets investments in the US$50 million to US$250 million range. For more information about Denham Capital, visit http://www.denhamcapital.com. Denham Capital does not provide investment advisory services to the public.

Contacts:

Biotherm Energy

Charles Liebenberg, CEO

+27 (0)11-300- 6153

Mobile: +27 (0)72 954 7116

cliebenberg@biothermenergy.com

Denham Capital Management

Gina Sorice

CJP Communications

+1 (212) 279-3115 ext 243

Mobile: +1 646 644 4046

gsorice@cjpcom.com

Michael Henman

Cubitt Consulting

Mobile: +44 (0)7740 038 930

michael.henman@cubitt.com


'/>"/>
SOURCE Denham Capital; BioTherm Energy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
4. ORNL resilience plan to help Tennessee, Mississippi and South Carolina communities beat disaster
5. BioSpace Launches 2nd Edition of Southern Pharm(TM) Hotbed Campaign
6. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
7. AG Mednet to Provide Image Network for Southwest Oncology Group
8. Physicians Practice, Loma Linda Partner to Improve Patient Care in Southern California
9. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
10. Medical University of South Carolina Opens State-of-the-Art Facility
11. Dr. Mark Nestor Presents on Pyratine-6(TM) at the South Beach Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Germany and GERMANTOWN, Maryland ... ; Frankfurt Prime Standard: QIA) today announced the introduction ... for gene expression profiling, expanding QIAGEN,s portfolio of Sample ... enable researchers to select from over 20,000 human genes ... interactions between genes, cellular phenotypes and disease processes. ...
(Date:2/11/2016)... CRUZ, Calif. , Feb. 11, 2016  Dovetail ... applications to its beta program for a planned metagenomic ... will present the company,s metagenomic genome assembly method in ... Advances in Genome Biology & Technology conference in ... assembly of these highly complex datasets is difficult. Using ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... stem cell treatment clinic in Quito, Ecuador. The new facility will provide advanced ... to patients from around the world. , The new GSCG clinic is ...
(Date:2/10/2016)... 2016 ASAE is introducing a hybrid membership ... (AMC) the option of joining or renewing through an ... by staff size, every employee in any size association ... reap all available member benefits.   John ... membership options will allow organizations of any size and ...
Breaking Biology Technology:
(Date:2/8/2016)... 2016 Worldcore is ... innovation for clients, comfort and unbeatable security, with ... --> Worldcore is the first EU-regulated ... comfort and unbeatable security, with a Voice Biometrics ... Worldcore is the first EU-regulated global payment ...
(Date:2/4/2016)... , Feb. 4, 2016 The ... apparently one of the most popular hubs of ... MetaHIT and other huge studies of human microbiota, ... past few years, the microbiome space has literally ... biomedical research. This report focuses on biomedical ...
(Date:2/3/2016)... February 3, 2016 --> ... research report "Automated Fingerprint Identification System Market by Component ... Application (Banking & Finance, Government, Healthcare, and Transportation) and ... the market is expected to be worth USD 8.49 ... between 2015 and 2020. The transformation and technology evolution ...
Breaking Biology News(10 mins):